![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Aurore Life Sciences Private Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for An integrated company with complete control of key starting materials, advanced intermediates & high-quality APIs.
One of their significant offerings is Raloxifene hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-165 - Rev 00
This Chemical Type CEP, issued on April 22, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2375 associated with this CEP further emphasizes